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Abstract: The primate T cell lymphotropic virus group comprises pathogenic and apathogenic agents found in human and 
simian hosts. Up to date, three types of the simian T cell lymphotropic virus/STLV and four types of the human T cell 
lymphotropic virus/HTLV have been isolated and characterized from non human primates and from human hosts respectively. 
We have not found evidences of STLV-1 infection among new world monkeys and besides fi ndings of HTLV-1 and 
HTLV-2 infection among brazilian mixed ethnic populations and Amerindians respectively, some unresolved HTLV inde-
terminate-Western blot results prevailed among human groups of different ethnic background. Based on recent serologic 
detection, isolation and characterization of HTLV-3 and HTLV-4 among African populations in central Africa and additional 
unrefutable evidences of early human migration from Africa and Australia to the American continent previously of Asiatic 
population migration lead us to hypothesize that human descendents of mixed Amerinds and Africans or remaining Africans 
explain the very frequent presence of Western blot-indeterminate results for HTLV-1/2 that we and other groups have been 
detecting and also the unusual absence of HTLV-2 infection among some relatively homogeneous ethnic native human 
populations in the American continent.
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Introduction
Recently Kanzaki and Casseb [1] described the unusual fi nding of HTLV-1 infection among Waiãpi 
Amazonian Amerindians. Also, among certain ethnic ancient groups, in the American Continent, it is 
very low the prevalence of both, HTLV-1 and HTLV-2 infection [2–5]. Colin et al. [6] found a very low 
prevalence to HTLV-1/2 infection in a human population in the Occidental Amazon (Acre/Brazil) despite 
other works showing high prevalence to HTLV-2 among Amerindian groups mainly in South America [1]. 
Besides these fi ndings, not so common among Amerindians, we and others have also found frequently 
HTLV-1/2 seroreactors by the Enzyme-linked immunosorbent assay /Immunofl uorescence (ELISA/IF) 
unconfi rmed by the Western blot analysis, but exhibiting isolated bands to one peptide or glycopeptide 
apparently related to deltaretroviruses [1,7,8]. In the beginning of the pioneering HTLV epidemiologi-
cal studies in Brazil, we suspected that the high incidence of HTLV-2 among some Amerindian eth-
nicities were related to a deltaretrovirus circulating among new world monkeys; therefore in order to 
corroborate this hypothesis we screened amazonian monkeys (58 Cebus paella, 5 Cebus albifrons, 
5 Cebus nigrivitatus, 6 Callicebus moloch, 13 Callithrix jaccus jacchus, 1 Callithrix argentata argen-
tata, 34 Aotus agarae infulatus, 2 Alouata belzebu belzebu and 10 Chiropotes satanas utahicki) for 
HTLV-1/2/STLV-1 antibodies by the ELISA test and found none reactive but we had 6 out of 24 african 
old world monkeys, Cercopithecus aethiops, highly reactive by the ELISA assay [7]. Other authors also 
could not fi nd HTLV-1/STLV-1 antibodies among new world monkeys [9,10] and confi rming that new 
world monkeys are not susceptible to HTLV-1 infection, new world squirrel monkeys (Saimiri sciureus) 
were experimentally infected by HTLV-1 infected cells as apparently these animals did not share cell 
receptors for the virus [11]. Despite Chen et al. [12] claims of STLV-2 isolation from Ateles fusciceps, 
a new world monkey in Panama, nobody else could demonstrate antibodies among new world monkeys 
neither isolate the virus again. Most of these HTLV-1 strains are serologically indistinguishable from 
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STLV-1 strains, as their viral genomes exhibit 
about 96% nucleotide homology which allow us 
to easily detect STLV-1 antibodies utilizing sero-
logic assays sensitized with HTLV-1 peptides [13]. 
Presently, it is assumed that the deltaretroviruses 
evolution occurred in Africa and very probably 
after the branching of new and old world monkeys’ 
ancestors [13,14].
According to different authors, during the 
Pleistocene/Holocene transition period, at least two 
different human populations migrated to the 
American Continent. Cranial anatomic analysis 
recognized two peculiar human morphologic 
patterns related to Asiatics and Africans, so con-
trary to the common sense, one of these groups, 
the Asiatics were not the fi rst human groups to 
migrate to the America continent, but the African 
group, probably coming from Oceania and/or 
Africa. Confi rming these fi ndings, Neves et al. [15] 
emphasizes that the colonization of the New World 
occurred by two distinct, succeeding biologi-
cal populations: an early one with a cranial 
morphology similar to that found today in the 
African and Australian continents, and a later one 
with a morphology similar to that found today 
among northeastern Asians.
Neves et al. [16] also have been finding 
increasing skeletal evidences from U.S.A., Mexico, 
Colombia, and Brazil strongly suggesting that the 
first settlers in the Americas had a cranial 
morphology distinct from that displayed by most 
late and modern native Americans.
Based on these research results and our unusual 
fi ndings of HTLV-1 infection among Amazonian 
amerinds, and indeterminate-Western blot profi les, 
we hypothesized that early human populations, the 
Australo-Melanesians and Africans that colonized 
the American continent 12.000–35.000 years in 
the past, previously to the migration of asian 
populations, by some way were not susceptible to 
HTLV-1 and 2 infection, and probably were mainly 
infected by other human deltaretroviruses.
The Primate T cell Lymphotropic 
Viruses
The Human T cell Lymphotropic Viruses are 
exogenous deltaretroviruses comprising four types, 
HTLV-1 to HTLV-4 [17–20]. The HTLVs and 
the Simian T Lymphotropic Viruses (STLVs) 
altogether are commonly denominated the Primate 
T Lymphotropic Viruses (PTLVs) due to their high 
nucleotide homology besides their common 
general genomic organization [21–23]. They were 
numbered according to their discoveries, not 
denotating the hierarchic fi logenetic positioning. 
Epidemiological and molecular studies point out 
to Africa as the motherland of these biological 
entities, which spread out to Asia, Europe and 
Oceania accompanying their hosts in their 
migrations [22,23].
Human Deltaretroviruses Evolution 
and Human Disease
As the deltaretroviruses are closely associated to 
the cell, their transmission mode are generally 
enclosed in familiar clusters, being transmitted by 
sexual intercourse, usually from man to woman 
and during breast-feeding, from mother to 
lactating children [24,25]. Their low mutation 
rate also confer them the maintenance of low 
pathogenicity behavior or depending on the type, 
their apathogenic role, therefore they are very 
successfully horizontally transmitted throughout 
generations [26,27]. Nevertheless, the human 
cultural development accompanied by population 
growth which consequently moved huge mass of 
people to more developed towns adding high levels 
of demographic density imposing exaggerated 
levels of stress and besides these factors, the 
advances in preventive and curative medicine have 
selected all kind of microorganisms by the survival 
of their human hosts. Also, climatic changes with 
elevated exposition to different wave length 
radiations, mainly ionizing radiation, have played 
an important role in the mutation rate of all kind 
of genetic elements in acellular and cellular organ-
isms [28]. Henceforth, taking in account all the 
facts mentioned, evolution has been in fast course 
and ultimately it seems to be in a rush at least in 
our knowledge of the modern civilization, in a way 
that apathogenic deltaretroviruses have been 
claimed to be involved in a large spectrum of 
diseases [29]. Comparing the human and deltaret-
rovirus genome from different time points, we can 
assume that the virus in a general way did not 
change at all, but human populations became much 
more vulnerable now than in the past to different 
microorganisms. Different vaccines, a lot of new 
chemical drugs and modern curative measures have 
been selecting less adapted human beings, so in 
these subjects the immune system does not respond 
appropriately, and an example of it are the 
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autoimmune diseases associated to HTLV-1 
infection among human beings [29–32].
Primate Deltaretroviruses 
Geographical Segregation
The emergence of STLVs after the evolutionary 
splitting of non human primates into new world 
and old world species avoided the spreading of 
STLVs to the American continent [22,23]. Several 
seroepidemiological studies in primate centres in 
the American continent could not fi nd STLV-1 
infection among new world monkeys.
It is interesting to note the distribution 
and segregation of HTLV-1 and HTLV-2 in 
cosmopolitan megalopolis and small towns in rural 
areas respectively, around the world [1,2,8,33]. 
Among Amerindian communities, HTLV-2 infec-
tion is widely spread out while HTLV-1 infection 
is mainly found among communities of African 
and Japanese origin, eventhough the intense human 
miscegenation in countries like Brazil, contributes 
to equal distribution of both HTLV types in human 
population as also, in the U.S. the epidemic 
HTLV-2 transmission among intravenous drug 
users changed the usual distribution pattern of 
human deltaretroviruses among different human 
ethnicities [8,33,34]. Examining HTLV-1 distribu-
tion in the world, historical facts try to explain the 
virus dissemination carried by their African hosts, 
in Portuguese commercial ships navigating to India 
and Japan, and lately in the slave trade period to 
the American continent and Caribbean basin. High 
levels of HTLV-1 prevalence is found in the Carib-
bean basin and Brazil among afrodescendents [35]. 
In Japan, the high HTLV-1 prevalence is not well 
understood as initially proposed by Africans trans-
portation in Portuguese trade ships in Japan [36]. 
Noteworthy to mention that STLV-1 is endemic 
among protected simians, Macaca fuscata, in 
japanese sanctuary mountains. Also, HTLV-1 is 
more related to the African strain of STLV-1 than 
to the Japanese strain. Would be the origin of 
HTLV-1 high incidence in Japanese human popu-
lations explained by STLV-1 natural human infec-
tion transmitted from Macaca fuscata? [37] Or by 
very ancient invasion of Japan archipellagus by 
paleo-Mongoloids human lineages more than 
10.000 years ago? [38]. By analogy to what is 
believed about SIV transmission from chipanzees 
to man and SIV mutation/adaptation to human 
target cells, generating HIV-1/2, which demanded 
a large step, while in the case of a possible 
transmission of STLV-1 from simians to man, 
would be a short step as both viruses, STLV-1 and 
HTLV-1 share about 96% nucleotide homology.
Particularly in Brazil, HTLV-1 prevalence is 
widespread, but mainly concentrates among black 
communities that arrived in Brazil during the slave 
trade period, contrasting to HTLV-2 prevalence 
which is high among Amerindian communities and 
intravenous drug users [39]. Despite this common 
sense, some exceptions occur, as the fi nding of 
HTLV-1 low prevalence among some Amerindian 
communities and any known reactivity to HTLV-2 
peptides [1]. Reviewing the literature, it seems that 
not only Amerindians colonized the American 
continent, but other ethnic groups have arrived 
earlier in the new world. The most antique of these 
human groups were Australo-Melanesians African 
descendents. Despite remnants fi ndings of these 
human groups spread out all over the continent, 
mainly abundant in Brazil, there seems actually to 
be vanished, nevertheless it is believed that few of 
them mixed to some other populations. Apparently 
the arrival of Asians to the continent through the 
Behring strait and the total occupation from 
north to south, must have anhilated the first 
human settlers in the American continent and as a 
common practice, very probably women and 
children became prisoners and mixed to the 
conquerors [15,16].
HTLV-1 and HTLV-2 Differences
When we look at the distribution of deltaretroviruses 
among human populations, it apparently means that 
ethnic pattern would determine which HTLV type 
would be housed by the host [35,36]. As previously 
mentioned, HTLV-2 is mainly disseminated among 
native Americans of asian origin, from North to 
South America [33,34,36,37,38] but curiously, some 
of these Amerindians groups exhibit low levels of 
HTLV-2 infection or do not express the virus at all 
in their cells [1,6]. How close are different human 
ethnic groups? Are genetic or cultural factors or both 
involved in more or less susceptibility to HTLVs 
infection? [34–36] Are these differences related to 
the levels of HTLV-1 or 2 infection susceptibility? 
[37,38]. Are so polymorphic the cell receptors for 
these viruses? [39] Anyway, why HTLV-1 is not 
reported to be well disseminated among intravenous 
drug users as it happens with HTLV-2? Would be 
their different biological behavior? It is very rare to 
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observe clinical diseases related to HTLV-2 
infection, but the frequency of HTLV-1 related 
disease occurrence is higher compared to HTLV-2. 
Genomic organization of both viruses are similar, 
but their cell targets are different [40,41]. While 
HTLV-1 preferentially infects CD4+ cells, HTLV-2 
exhibits CD8+ tropism. As it is well known, 
CD4+ cells are functionally more important than 
CD8+ cells, which mainly exerts a fi nal effector 
function as a cytotoxic cell. [42,43].
Hypotheses
In all seroepidemiological surveys we have 
conducted among Amerindian communities and 
mixed ethnic populations, there is a high frequency 
of indeterminate Western blot results [1,7]. 
Reviewing the literature, recently, two new HTLV 
types were identified in Africa, HTLV-3 and 
HTLV-4, and curiously, in serological assays 
screening for HTLV-1 and 2 antibodies, people 
infected by HTLV-3 or 4, displayed Western blot 
isolated bands similarly to indeterminate results as 
we have found among our samples [17–19]. Future 
studies would corroborate these assumptions and 
would reinforce our hypothesis of vestiges of 
Australo-Melanesians and africans among our 
isolated native communities, explaining therefore 
the unusual absence of HTLV-2 infection among 
some Amerindian communities, interfered by 
HTLV-3/4 infection.
Conclusion
Unusual fi nding of HTLV-1 infection among some 
Amerindian communities and in some cases, the 
absence of HTLV-2 infection among some other 
Amerindian communities besides the frequency of 
indeterminate-Western blot bands to HTLV-1 and 
2 antibodies, strongly suggest the circulation of 
other deltaretroviruses among Amerindians and 
mixed ethnic populations in the American 
continent. Also, we have associated this hypothesis 
to the recent theory of earlier Australo-Melanesians 
and African descendents migrations to the 
American continent, carrying with them HTLV-3 
and 4. Very probably remnants of these populations 
or the dominance of their HLA alleles in the mixed 
descendents could be responsible for immune 
response to HTLV-3/4 yielding interference to 
HTLV-1/2 infection (44–48). As previously 
discussed, HTLV-1/2 transmission in nuclear 
families would determine viral antigens immune 
tolerance as earlier proposed by Medawar (1983), 
mainly among newborn [49], but later, 40 or 
50 years, a small percentage of these infected 
subjects would develop an HTLV-1 related disease, 
as tolerance would break up, favored by the 
immune system aging associated to a number of 
environmental factors exposure.
Our preliminary studies corroborated by others 
could not support the initial hypothesis in the early 
epidemiological studies in Brazil of a possible 
transmission of a deltaretrovirus from new world 
monkeys to native Amazonians. Until now, any 
known deltaretrovirus has not yet been isolated 
from new world monkeys.
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